Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement C3dg is a stable, long-lived proteolytic cleavage fragment of complement component 3 (C3) that remains covalently bound to cell surfaces and tissues at sites of complement activation. It is generated when C3b is sequentially cleaved by factor I and its cofactors into iC3b, and subsequently into C3dg and C3c. C3dg plays a critical role in bridging innate and adaptive immunity by interacting with complement receptor 2 (CR2/CD21) on B cells to lower the threshold for B cell activation, and with complement receptor 3 (CR3) on phagocytes to facilitate opsonization and phagocytosis. Because of its covalent attachment and prolonged tissue residence time, C3dg serves as an attractive target for tissue-localized complement inhibitors, such as ADX-097 (AKB-097) and TT30. These therapeutic fusion proteins utilize C3dg/C3d-binding domains to deliver complement regulatory proteins (like Factor H) directly to damaged tissues, thereby selectively inhibiting the complement cascade locally while preserving systemic complement activity and reducing the risk of systemic infections.
Tissue-targeted complement inhibition by binding to C3dg/C3d deposited at sites of complement activation, delivering a complement regulatory domain (such as Factor H) to locally inhibit the alternative pathway convertases without causing systemic complement blockade.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement C3dg fragment (C3dg).